NASDAQ: STLN
Starling Oncology Inc Stock Ownership - Who owns Starling Oncology?

Insider buying vs selling

Have Starling Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jorey Chernett10% Owner2026-07-2118,000$5.27
$94.86kBuy
Yale PodnosChief2026-07-145,478$6.35
$34.79kSell
Yale PodnosChief2026-07-145,478$2.00
$10.96kBuy
Yale PodnosChief2026-07-1417,974$6.43
$115.55kSell
Yale PodnosChief2026-07-1417,974$1.87
$33.61kBuy
Jorey Chernett10% Owner2026-07-1015,000$5.85
$87.75kBuy
Jorey Chernett10% Owner2026-06-2318,000$5.02
$90.36kBuy
Yale PodnosChief Medical Officer2026-06-0823,451$5.38
$126.10kSell
Jorey Chernett10% Owner2026-06-0412,000$4.75
$57.00kBuy
Yale PodnosChief Medical Officer2026-05-211,805$4.47
$8.07kSell

1 of 5

STLN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STLN insiders and whales buy or sell their stock.

STLN Shareholders

What type of owners hold Starling Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ravi Yang Sarin12.17%12,404,740$62.40MInsider
Jorey Chernett10.45%10,648,858$53.56MInsider
Richard A. Barasch6.99%7,126,571$35.85MInsider
M33 Growth I LP5.34%5,444,207$27.38MInsider
Blackrock Inc4.33%4,415,867$22.21MInstitution
Vanguard Capital Management LLC3.41%3,476,781$17.49MInstitution
Deerfield Management Company LP3.30%3,360,052$16.90MInstitution
James E. Flynn3.23%3,296,107$16.58MInsider
Kanen Wealth Management LLC2.73%2,777,858$13.97MInstitution
Josh Arnold Investment Consultant LLC2.42%2,464,359$12.40MInstitution

1 of 3

STLN vs Medical Care Facility Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STLN38.03%45.63%Net SellingNet Buying
MCTA0.24%11.64%
CYH62.64%37.36%Net Selling
AUNA9.46%49.14%Net BuyingNet Buying
GMRS0.00%40.82%Net SellingNet Buying

Starling Oncology Stock Ownership FAQ

Who owns Starling Oncology?

Starling Oncology (NASDAQ: STLN) is owned by 38.03% institutional shareholders, 45.63% Starling Oncology insiders, and 16.34% retail investors. Ravi Yang Sarin is the largest individual Starling Oncology shareholder, owning 12.40M shares representing 12.17% of the company. Ravi Yang Sarin's Starling Oncology shares are currently valued at $62.40M.

If you're new to stock investing, here's how to buy Starling Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.